Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Paratek Pharmaceuticals Inc banner
P

Paratek Pharmaceuticals Inc
F:N4CN

Watchlist Manager
Paratek Pharmaceuticals Inc
F:N4CN
Watchlist
Price: 2.024 EUR Market Closed
Market Cap: €115.9m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

N4CN Price Targets Summary
Paratek Pharmaceuticals Inc

There are no price targets for N4CN.
N4CN Lowest Forecast
Wall Street Target
Not Available
N4CN Average Forecast
Wall Street Target
Not Available
N4CN Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Paratek Pharmaceuticals Inc Competitors:
Price Targets
SMG
Scotts Miracle-Gro Co
11% Upside
SMG
Scotts Miracle-Gro Co
11% Upside

Revenue
Forecast

57% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
57% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 8 years the compound annual growth rate for Paratek Pharmaceuticals Inc's revenue is 57%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Paratek Pharmaceuticals Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

What are analyst estimates?

See Also

Summary
N4CN intrinsic value, competitors valuation, and company profile.
DCF Valuation
N4CN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
N4CN stock valuation using valuation multiples.
Wall Street Estimates
N4CN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
N4CN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is N4CN's stock price target?
Not Available

N4CN doesn't have any price targets made by Wall Street professionals.

Back to Top
ALPHA SPREAD
Follow us
Join more than 316,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.